Inflammatory markers and in-hospital mortality in acute ischaemic stroke.

[1]  J. Sejvar,et al.  Risk of Elective Major Noncardiac Surgery After Coronary Stent Insertion , 2012 .

[2]  J. Aarseth,et al.  IL‐6: an early marker for outcome in acute ischemic stroke , 2005, Acta neurologica Scandinavica.

[3]  P. Heuschmann,et al.  Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. , 2004, Archives of internal medicine.

[4]  G. Rosano,et al.  PLASMA LEVELS OF INFLAMMATORY C‐REACTIVE PROTEIN AND INTERLEUKIN‐6 PREDICT OUTCOME IN ELDERLY PATIENTS WITH STROKE , 2004, Journal of the American Geriatrics Society.

[5]  N. Rothwell,et al.  Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome , 2004, BMC neurology.

[6]  Á. Chamorro.  Role of Inflammation in Stroke and Atherothrombosis , 2004, Cerebrovascular Diseases.

[7]  H. Diener,et al.  Organization of Stroke Care: Education, Referral, Emergency Management and Imaging, Stroke Units and Rehabilitation , 2003, Cerebrovascular Diseases.

[8]  H. Monyer,et al.  Regulation of Body Temperature and Neuroprotection by Endogenous Interleukin-6 in Cerebral Ischemia , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  Nikolaos Laoutaris,et al.  Prognostic Value of C‐Reactive Protein, Fibrinogen, Interleukin‐6, and Macrophage Colony Stimulating Factor in Severe Unstable Angina , 2002, Clinical cardiology.

[10]  B. Conrad,et al.  Prognostic Relevance of Early Serial C-Reactive Protein Measurements After First Ischemic Stroke , 2002, Stroke.

[11]  M. Di Napoli,et al.  Inflammation, Hemostatic Markers, and Antithrombotic Agents in Relation to Long-Term Risk of New Cardiovascular Events in First-Ever Ischemic Stroke Patients , 2002, Stroke.

[12]  Á. Chamorro,et al.  Inflammation-Mediated Damage in Progressing Lacunar Infarctions: A Potential Therapeutic Target , 2002, Stroke.

[13]  D. Stirling,et al.  Interleukin 6 and Haemostasis , 2001, British journal of haematology.

[14]  S. Abilleira,et al.  Correlación entre la expresión de citocinas proinflamatorias y metaloproteinasas de matriz en la fase aguda del ictus isquémico , 2001 .

[15]  Á. Chamorro,et al.  Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke , 2000, Stroke.

[16]  G. Feuerstein,et al.  Inflammation and Stroke: Putative Role for Cytokines, Adhesion Molecules and iNOS in Brain Response to Ischemia , 2000, Brain pathology.

[17]  W. Reinhart,et al.  C-reactive protein (CRP) in cerebro-vascular events. , 1999, Atherosclerosis.

[18]  K. Wong,et al.  Risk Factors for Early Death in Acute Ischemic Stroke and Intracerebral Hemorrhage A Prospective Hospital-Based Study in Asia , 1999 .

[19]  E. Nagata,et al.  Temporal Profile and Cellular Localization of Interleukin-6 Protein after Focal Cerebral Ischemia in Rats , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  F. Sarinella,et al.  Increased Cytokine Release from Peripheral Blood Cells after Acute Stroke , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  K. Lees,et al.  C-reactive protein and outcome after ischemic stroke. , 1999, Stroke.

[22]  T. Yamada,et al.  Serum Amyloid A (SAA): a Concise Review of Biology, Assay Methods and Clinical Usefulness , 1999, Clinical chemistry and laboratory medicine.

[23]  S. Ekholm,et al.  Intrathecal expression of proteins regulating apoptosis in acute stroke. , 1999, Stroke.

[24]  L. Pantoni,et al.  Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[25]  N. Bornstein,et al.  Does daily aspirin diminish severity of first-ever stroke? , 1997, Archives of neurology.

[26]  G. Ciliberto,et al.  Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. , 1997, Immunity.

[27]  Y. Kim,et al.  Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. , 1996, Stroke.

[28]  S. Ekholm,et al.  Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. , 1995, Stroke.

[29]  J. Pruvo,et al.  Early predictors of death and disability after acute cerebral ischemic event. , 1995, Stroke.

[30]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[31]  T. Kammer,et al.  Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease , 1994, Journal of the Neurological Sciences.

[32]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[33]  P. Kochanek,et al.  Polymorphonuclear Leukocytes and Monocytes/Macrophages in the Pathogenesis of Cerebral Ischemia and Stroke , 1992, Stroke.

[34]  J. Gauldie,et al.  Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. , 1990, Molecular biology & medicine.

[35]  D. Stern,et al.  Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.